Revenue - By Product (Details) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Mar. 31, 2025	Mar. 31, 2024	Mar. 31, 2025	Mar. 31, 2024
Segment Reporting Information [Line Items]
Revenue	[1]	$ 92,793	$ 75,302	$ 181,506	$ 146,800
Synthetic genes
Segment Reporting Information [Line Items]
Revenue		28,222	22,356	54,708	42,083
Oligo pools
Segment Reporting Information [Line Items]
Revenue		4,711	3,940	9,804	8,129
DNA libraries
Segment Reporting Information [Line Items]
Revenue		3,017	3,531	5,811	6,470
Antibody discovery
Segment Reporting Information [Line Items]
Revenue		5,697	4,701	11,395	9,927
NGS tools
Segment Reporting Information [Line Items]
Revenue		$ 51,146	$ 40,774	$ 99,788	$ 80,191

[1] During the three and six months ended March 31, 2025, the Company had revenues from related parties in the amount of $2.8 million and $6.8 million, respectively. During the three and six months ended March 31, 2024, the Company had revenues from related parties in the amount of $3.2 million and $5.6 million, respectively.